BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mukherjea D, Jajoo S, Kaur T, Sheehan KE, Ramkumar V, Rybak LP. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Antioxid Redox Signal. 2010;13:589-598. [PMID: 20214492 DOI: 10.1089/ars.2010.3110] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Wong ACY. Noise-induced hearing loss in the 21 st century: A research and translational update. WJO 2013;3:58. [DOI: 10.5319/wjo.v3.i3.58] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 2] [Article Influence: 1.9] [Reference Citation Analysis]
2 Mukherjea D, Dhukhwa A, Sapra A, Bhandari P, Woolford K, Franke J, Ramkumar V, Rybak L. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity. Expert Opin Drug Metab Toxicol 2020;16:965-82. [PMID: 32757852 DOI: 10.1080/17425255.2020.1806235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Little AC, Sulovari A, Danyal K, Heppner DE, Seward DJ, van der Vliet A. Paradoxical roles of dual oxidases in cancer biology. Free Radic Biol Med 2017;110:117-32. [PMID: 28578013 DOI: 10.1016/j.freeradbiomed.2017.05.024] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
4 Wang A, Hou N, Bao D, Liu S, Xu T. Mechanism of alpha-lipoic acid in attenuating kanamycin-induced ototoxicity. Neural Regen Res 2012;7:2793-800. [PMID: 25317129 DOI: 10.3969/j.issn.1673-5374.2012.35.007] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
5 Bouron A, Kiselyov K, Oberwinkler J. Permeation, regulation and control of expression of TRP channels by trace metal ions. Pflugers Arch 2015;467:1143-64. [PMID: 25106481 DOI: 10.1007/s00424-014-1590-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 7.9] [Reference Citation Analysis]
6 Yang P, Huang S, Yan X, Huang G, Dong X, Zheng T, Yuan D, Wang R, Li R, Tan Y, Xu A. Origin of the phagocytic respiratory burst and its role in gut epithelial phagocytosis in a basal chordate. Free Radic Biol Med 2014;70:54-67. [PMID: 24560860 DOI: 10.1016/j.freeradbiomed.2014.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
7 Jin S, Zhou F, Katirai F, Li PL. Lipid raft redox signaling: molecular mechanisms in health and disease. Antioxid Redox Signal 2011;15:1043-83. [PMID: 21294649 DOI: 10.1089/ars.2010.3619] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 8.1] [Reference Citation Analysis]
8 Jimenez JE, Nourbakhsh A, Colbert B, Mittal R, Yan D, Green CL, Nisenbaum E, Liu G, Bencie N, Rudman J, Blanton SH, Zhong Liu X. Diagnostic and therapeutic applications of genomic medicine in progressive, late-onset, nonsyndromic sensorineural hearing loss. Gene 2020;747:144677. [PMID: 32304785 DOI: 10.1016/j.gene.2020.144677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Vlajkovic SM, Lin SC, Wong AC, Wackrow B, Thorne PR. Noise-induced changes in expression levels of NADPH oxidases in the cochlea. Hear Res. 2013;304C:145-152. [PMID: 23899412 DOI: 10.1016/j.heares.2013.07.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
10 Wick CC, Semaan MT, Zheng QY, Megerian CA. A Genetic Murine Model of Endolymphatic Hydrops: The Phex Mouse. Curr Otorhinolaryngol Rep 2014;2:144-51. [PMID: 25309828 DOI: 10.1007/s40136-014-0048-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
11 Hastings ML, Jones TA. Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction. Neurotherapeutics 2019;16:348-59. [PMID: 30972560 DOI: 10.1007/s13311-019-00729-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
12 Yu D, Gu J, Chen Y, Kang W, Wang X, Wu H. Current Strategies to Combat Cisplatin-Induced Ototoxicity. Front Pharmacol 2020;11:999. [PMID: 32719605 DOI: 10.3389/fphar.2020.00999] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
13 Kaur T, Borse V, Sheth S, Sheehan K, Ghosh S, Tupal S, Jajoo S, Mukherjea D, Rybak LP, Ramkumar V. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea. J Neurosci 2016;36:3962-77. [PMID: 27053204 DOI: 10.1523/JNEUROSCI.3111-15.2016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
14 Özkaya D, Nazıroğlu M. Curcumin diminishes cisplatin-induced apoptosis and mitochondrial oxidative stress through inhibition of TRPM2 channel signaling pathway in mouse optic nerve. J Recept Signal Transduct Res 2020;40:97-108. [PMID: 32019426 DOI: 10.1080/10799893.2020.1720240] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
15 Mukherjea D, Jajoo S, Sheehan K, Kaur T, Sheth S, Bunch J, Perro C, Rybak LP, Ramkumar V. NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss. Antioxid Redox Signal 2011;14:999-1010. [PMID: 20712533 DOI: 10.1089/ars.2010.3497] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
16 Du Z, Yang Q, Zhou T, Liu L, Li S, Chen S, Gao C. D‑galactose‑induced mitochondrial DNA oxidative damage in the auditory cortex of rats. Mol Med Rep 2014;10:2861-7. [PMID: 25324030 DOI: 10.3892/mmr.2014.2653] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
17 Altenhöfer S, Radermacher KA, Kleikers PW, Wingler K, Schmidt HH. Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement. Antioxid Redox Signal 2015;23:406-27. [PMID: 24383718 DOI: 10.1089/ars.2013.5814] [Cited by in Crossref: 288] [Cited by in F6Publishing: 267] [Article Influence: 41.1] [Reference Citation Analysis]
18 Kim HJ, Oh GS, Shen A, Lee SB, Khadka D, Pandit A, Shim H, Yang SH, Cho EY, Song J, Kwak TH, Choe SK, Park R, So HS. Nicotinamide adenine dinucleotide: An essential factor in preserving hearing in cisplatin-induced ototoxicity. Hear Res 2015;326:30-9. [PMID: 25891352 DOI: 10.1016/j.heares.2015.04.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Mohri H, Ninoyu Y, Sakaguchi H, Hirano S, Saito N, Ueyama T. Nox3-Derived Superoxide in Cochleae Induces Sensorineural Hearing Loss. J Neurosci 2021;41:4716-31. [PMID: 33849947 DOI: 10.1523/JNEUROSCI.2672-20.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Hempel N, Trebak M. Crosstalk between calcium and reactive oxygen species signaling in cancer. Cell Calcium 2017;63:70-96. [PMID: 28143649 DOI: 10.1016/j.ceca.2017.01.007] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 23.3] [Reference Citation Analysis]
21 Nan B, Gu X, Huang X. The Role of the Reactive Oxygen Species Scavenger Agent, Astaxanthin, in the Protection of Cisplatin-Treated Patients Against Hearing Loss. Drug Des Devel Ther 2019;13:4291-303. [PMID: 31908415 DOI: 10.2147/DDDT.S212313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Bhatta P, Dhukhwa A, Sheehan K, Al Aameri RFH, Borse V, Ghosh S, Sheth S, Mamillapalli C, Rybak L, Ramkumar V, Mukherjea D. Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea. Sci Rep 2019;9:4131. [PMID: 30858408 DOI: 10.1038/s41598-019-40425-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
23 Du Z, Yang Y, Hu Y, Sun Y, Zhang S, Peng W, Zhong Y, Huang X, Kong W. A long-term high-fat diet increases oxidative stress, mitochondrial damage and apoptosis in the inner ear of d-galactose-induced aging rats. Hearing Research 2012;287:15-24. [DOI: 10.1016/j.heares.2012.04.012] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 7.4] [Reference Citation Analysis]
24 Nourbakhsh A, Colbert BM, Nisenbaum E, El-Amraoui A, Dykxhoorn DM, Koehler KR, Chen ZY, Liu XZ. Stem Cells and Gene Therapy in Progressive Hearing Loss: the State of the Art. J Assoc Res Otolaryngol 2021;22:95-105. [PMID: 33507440 DOI: 10.1007/s10162-020-00781-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Jones QR, Warford J, Rupasinghe HP, Robertson GS. Target-based selection of flavonoids for neurodegenerative disorders. Trends Pharmacol Sci 2012;33:602-10. [PMID: 22980637 DOI: 10.1016/j.tips.2012.08.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 7.0] [Reference Citation Analysis]
26 Tang Q, Wang X, Jin H, Mi Y, Liu L, Dong M, Chen Y, Zou Z. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies. Eur J Pharm Biopharm 2021;163:60-71. [PMID: 33775853 DOI: 10.1016/j.ejpb.2021.03.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Cooney SJ, Zhao Y, Byrnes KR. Characterization of the expression and inflammatory activity of NADPH oxidase after spinal cord injury. Free Radic Res 2014;48:929-39. [PMID: 24866054 DOI: 10.3109/10715762.2014.927578] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
28 Katsuyama M, Matsuno K, Yabe-Nishimura C. Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme. J Clin Biochem Nutr. 2012;50:9-22. [PMID: 22247596 DOI: 10.3164/jcbn.11-06SR] [Cited by in Crossref: 67] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
29 Oishi N, Chen FQ, Zheng HW, Sha SH. Intra-tympanic delivery of short interfering RNA into the adult mouse cochlea. Hear Res 2013;296:36-41. [PMID: 23183031 DOI: 10.1016/j.heares.2012.10.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
30 Irving S, Gillespie L, Richardson R, Rowe D, Fallon JB, Wise AK. Electroacoustic stimulation: now and into the future. Biomed Res Int 2014;2014:350504. [PMID: 25276779 DOI: 10.1155/2014/350504] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
31 Kohrman DC, Raphael Y. Gene therapy for deafness. Gene Ther 2013;20:1119-23. [PMID: 23864018 DOI: 10.1038/gt.2013.39] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
32 Fujimoto C, Yamasoba T. Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review. Antioxidants (Basel) 2019;8:E109. [PMID: 31022870 DOI: 10.3390/antiox8040109] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
33 Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, Daiber A. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol 2017;13:94-162. [PMID: 28577489 DOI: 10.1016/j.redox.2017.05.007] [Cited by in Crossref: 154] [Cited by in F6Publishing: 129] [Article Influence: 38.5] [Reference Citation Analysis]
34 Dash-Wagh S, Jacob S, Lindberg S, Fridberger A, Langel U, Ulfendahl M. Intracellular Delivery of Short Interfering RNA in Rat Organ of Corti Using a Cell-penetrating Peptide PepFect6. Mol Ther Nucleic Acids 2012;1:e61. [PMID: 23232329 DOI: 10.1038/mtna.2012.50] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
35 You X, Ma M, Hou G, Hu Y, Shi X. Gene expression and prognosis of NOX family members in gastric cancer. Onco Targets Ther 2018;11:3065-74. [PMID: 29872318 DOI: 10.2147/OTT.S161287] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
36 Santabarbara G, Maione P, Rossi A, Gridelli C. Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy. Expert Opinion on Pharmacotherapy 2015;17:561-70. [DOI: 10.1517/14656566.2016.1122757] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
37 Fukui H, Raphael Y. Gene therapy for the inner ear. Hear Res 2013;297:99-105. [PMID: 23265411 DOI: 10.1016/j.heares.2012.11.017] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
38 Karasawa T, Steyger PS. An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicol Lett 2015;237:219-27. [PMID: 26101797 DOI: 10.1016/j.toxlet.2015.06.012] [Cited by in Crossref: 221] [Cited by in F6Publishing: 190] [Article Influence: 36.8] [Reference Citation Analysis]
39 Cao X, Zhang W, Moore PK, Bian J. Protective Smell of Hydrogen Sulfide and Polysulfide in Cisplatin-Induced Nephrotoxicity. Int J Mol Sci 2019;20:E313. [PMID: 30646560 DOI: 10.3390/ijms20020313] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
40 Bielefeld EC, Tanaka C, Chen G, Coling D, Li M, Henderson D, Fetoni AR. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect. Anti-Cancer Drugs 2013;24:43-51. [DOI: 10.1097/cad.0b013e32835739fd] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Laurell G, Videhult Pierre P. Hearing Loss After Cisplatin: Oxidative Stress Pathways and Potential for Protection. In: Miller J, Le Prell CG, Rybak L, editors. Free Radicals in ENT Pathology. Cham: Springer International Publishing; 2015. pp. 217-41. [DOI: 10.1007/978-3-319-13473-4_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Gunewardene N. Adenosine amine congener ameliorates cisplatin-induced hearing loss. WJO 2013;3:100. [DOI: 10.5319/wjo.v3.i3.100] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Lavinsky J, Crow AL, Pan C, Wang J, Aaron KA, Ho MK, Li Q, Salehide P, Myint A, Monges-Hernadez M, Eskin E, Allayee H, Lusis AJ, Friedman RA. Genome-wide association study identifies nox3 as a critical gene for susceptibility to noise-induced hearing loss. PLoS Genet 2015;11:e1005094. [PMID: 25880434 DOI: 10.1371/journal.pgen.1005094] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
44 Tan WJ. Noise-induced cochlear inflammation. WJO 2013;3:89. [DOI: 10.5319/wjo.v3.i3.89] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.9] [Reference Citation Analysis]
45 Yang HC, Cheng ML, Ho HY, Chiu DT. The microbicidal and cytoregulatory roles of NADPH oxidases. Microbes Infect 2011;13:109-20. [PMID: 20971207 DOI: 10.1016/j.micinf.2010.10.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
46 Rousset F, Nacher-Soler G, Coelho M, Ilmjarv S, Kokje VBC, Marteyn A, Cambet Y, Perny M, Roccio M, Jaquet V, Senn P, Krause KH. Redox activation of excitatory pathways in auditory neurons as mechanism of age-related hearing loss. Redox Biol 2020;30:101434. [PMID: 32000019 DOI: 10.1016/j.redox.2020.101434] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
47 Cocetta V, Ragazzi E, Montopoli M. Links between cancer metabolism and cisplatin resistance. Int Rev Cell Mol Biol 2020;354:107-64. [PMID: 32475471 DOI: 10.1016/bs.ircmb.2020.01.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
48 Morioka S, Sakaguchi H, Yamaguchi T, Ninoyu Y, Mohri H, Nakamura T, Hisa Y, Ogita K, Saito N, Ueyama T. Hearing vulnerability after noise exposure in a mouse model of reactive oxygen species overproduction. J Neurochem 2018;146:459-73. [PMID: 29675997 DOI: 10.1111/jnc.14451] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
49 Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection. Front Cell Neurosci 2017;11:338. [PMID: 29163050 DOI: 10.3389/fncel.2017.00338] [Cited by in Crossref: 117] [Cited by in F6Publishing: 94] [Article Influence: 29.3] [Reference Citation Analysis]
50 Casares C, Ramírez-camacho R, Trinidad A, Roldán A, Jorge E, García-berrocal JR. Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models. Eur Arch Otorhinolaryngol 2012;269:2455-9. [DOI: 10.1007/s00405-012-2029-0] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 9.6] [Reference Citation Analysis]
51 Sakallı Çetin E, Nazıroğlu M, Çiğ B, Övey İS, Aslan Koşar P. Selenium potentiates the anticancer effect of cisplatin against oxidative stress and calcium ion signaling-induced intracellular toxicity in MCF-7 breast cancer cells: involvement of the TRPV1 channel. Journal of Receptors and Signal Transduction 2017;37:84-93. [DOI: 10.3109/10799893.2016.1160931] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
52 Audo I, Warchol ME. Retinal and cochlear toxicity of drugs: new insights into mechanisms and detection. Curr Opin Neurol 2012;25:76-85. [PMID: 22157108 DOI: 10.1097/WCO.0b013e32834ed882] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
53 Wilson T, Omelchenko I, Foster S, Zhang Y, Shi X, Nuttall AL. JAK2/STAT3 inhibition attenuates noise-induced hearing loss. PLoS One 2014;9:e108276. [PMID: 25275304 DOI: 10.1371/journal.pone.0108276] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
54 Bonventre JV, Yang L. Kidney injury molecule-1. Curr Opin Crit Care 2010;16:556-61. [PMID: 20930626 DOI: 10.1097/MCC.0b013e32834008d3] [Cited by in Crossref: 76] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
55 Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W. Metal Drugs and the Anticancer Immune Response. Chem Rev 2019;119:1519-624. [DOI: 10.1021/acs.chemrev.8b00396] [Cited by in Crossref: 108] [Cited by in F6Publishing: 78] [Article Influence: 36.0] [Reference Citation Analysis]
56 Lee MY, Park YH. Potential of Gene and Cell Therapy for Inner Ear Hair Cells. Biomed Res Int. 2018;2018:8137614. [PMID: 30009175 DOI: 10.1155/2018/8137614] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
57 Waissbluth S, Pitaro J, Daniel SJ. Gene therapy for cisplatin-induced ototoxicity: a systematic review of in vitro and experimental animal studies. Otol Neurotol 2012;33:302-10. [PMID: 22388732 DOI: 10.1097/MAO.0b013e318248ee66] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
58 Chirtes F, Albu S. Prevention and restoration of hearing loss associated with the use of cisplatin. Biomed Res Int 2014;2014:925485. [PMID: 25140325 DOI: 10.1155/2014/925485] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
59 Li D, Zhao H, Cui ZK, Tian G. The Role of Nrf2 in Hearing Loss. Front Pharmacol 2021;12:620921. [PMID: 33912042 DOI: 10.3389/fphar.2021.620921] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Flaherty JP, Fairfield HE, Spruce CA, McCarty CM, Bergstrom DE. Molecular characterization of an allelic series of mutations in the mouse Nox3 gene. Mamm Genome 2011;22:156-69. [PMID: 21161235 DOI: 10.1007/s00335-010-9309-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
61 Schacht J, Talaska AE, Rybak LP. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec (Hoboken). 2012;295:1837-1850. [PMID: 23045231 DOI: 10.1002/ar.22578] [Cited by in Crossref: 188] [Cited by in F6Publishing: 150] [Article Influence: 20.9] [Reference Citation Analysis]
62 Mukherjea D, Rybak LP, Sheehan KE, Kaur T, Ramkumar V, Jajoo S, Sheth S. The design and screening of drugs to prevent acquired sensorineural hearing loss. Expert Opin Drug Discov 2011;6:491-505. [PMID: 22646075 DOI: 10.1517/17460441.2011.562887] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
63 Sheth S, Mukherjea D, Rybak LP, Ramkumar V. The Contribution of Anti-oxidant and Anti-inflammatory Functions of Adenosine A1 Receptor in Mediating Otoprotection. In: Ramkumar V, Rybak LP, editors. Inflammatory Mechanisms in Mediating Hearing Loss. Cham: Springer International Publishing; 2018. pp. 149-64. [DOI: 10.1007/978-3-319-92507-3_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Youm I, West MB, Li W, Du X, Ewert DL, Kopke RD. siRNA-loaded biodegradable nanocarriers for therapeutic MAPK1 silencing against cisplatin-induced ototoxicity. Int J Pharm 2017;528:611-23. [PMID: 28627458 DOI: 10.1016/j.ijpharm.2017.06.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
65 Tropitzsch A, Arnold H, Bassiouni M, Müller A, Eckhard A, Müller M, Löwenheim H. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity. Toxicol Lett 2014;227:203-12. [PMID: 24709139 DOI: 10.1016/j.toxlet.2014.03.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
66 Shin YS, Song SJ, Kang SU, Hwang HS, Choi JW, Lee BH, Jung YS, Kim CH. A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study. Neuroscience 2013;232:1-12. [PMID: 23246618 DOI: 10.1016/j.neuroscience.2012.12.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
67 Dinh C, Bas E, Dinh J, Vu L, Gupta C, Van De Water TR. Short interfering RNA against Bax attenuates TNFα-induced ototoxicity in rat organ of Corti explants. Otolaryngol Head Neck Surg 2013;148:834-40. [PMID: 23401256 DOI: 10.1177/0194599813477631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
68 Kim YJ, Kim J, Tian C, Lim HJ, Kim YS, Chung JH, Choung YH. Prevention of cisplatin-induced ototoxicity by the inhibition of gap junctional intercellular communication in auditory cells. Cell Mol Life Sci 2014;71:3859-71. [PMID: 24623558 DOI: 10.1007/s00018-014-1594-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
69 Musazzi UM, Franzé S, Cilurzo F. Innovative pharmaceutical approaches for the management of inner ear disorders. Drug Deliv Transl Res 2018;8:436-49. [PMID: 28462501 DOI: 10.1007/s13346-017-0384-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
70 Rodrigues JC, Bachi ALL, Silva GAV, Rossi M, do Amaral JB, Lezirovitz K, de Brito R. New Insights on the Effect of TNF Alpha Blockade by Gene Silencing in Noise-Induced Hearing Loss. Int J Mol Sci 2020;21:E2692. [PMID: 32294929 DOI: 10.3390/ijms21082692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
71 Du Z, Yang Q, Liu L, Li S, Zhao J, Hu J, Liu C, Qian D, Gao C. NADPH oxidase 2-dependent oxidative stress, mitochondrial damage and apoptosis in the ventral cochlear nucleus of d-galactose-induced aging rats. Neuroscience 2015;286:281-92. [DOI: 10.1016/j.neuroscience.2014.11.061] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
72 Gentilin E, Simoni E, Candito M, Cazzador D, Astolfi L. Cisplatin-Induced Ototoxicity: Updates on Molecular Targets. Trends in Molecular Medicine 2019;25:1123-32. [DOI: 10.1016/j.molmed.2019.08.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
73 Rasoulian B, Kaeidi A, Rezaei M, Hajializadeh Z. Cellular Preoxygenation Partially Attenuates the Antitumoral Effect of Cisplatin despite Highly Protective Effects on Renal Epithelial Cells. Oxid Med Cell Longev 2017;2017:7203758. [PMID: 28298953 DOI: 10.1155/2017/7203758] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
74 Du Z, Li S, Liu L, Yang Q, Zhang H, Gao C. NADPH oxidase 3‑associated oxidative stress and caspase 3‑dependent apoptosis in the cochleae of D‑galactose‑induced aged rats. Mol Med Rep 2015;12:7883-90. [PMID: 26498835 DOI: 10.3892/mmr.2015.4430] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
75 Kaur T, Mukherjea D, Sheehan K, Jajoo S, Rybak LP, Ramkumar V. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation. Cell Death Dis. 2011;2:e180. [PMID: 21776018 DOI: 10.1038/cddis.2011.63] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 8.9] [Reference Citation Analysis]
76 Ciuman RR. Inner ear symptoms and disease: pathophysiological understanding and therapeutic options. Med Sci Monit. 2013;19:1195-1210. [PMID: 24362017 DOI: 10.12659/msm.889815] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
77 Oishi N, Talaska AE, Schacht J. Ototoxicity in dogs and cats. Vet Clin North Am Small Anim Pract 2012;42:1259-71. [PMID: 23122180 DOI: 10.1016/j.cvsm.2012.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
78 Rybak LP, Mukherjea D, Jajoo S, Kaur T, Ramkumar V. siRNA-mediated knock-down of NOX3: therapy for hearing loss? Cell Mol Life Sci 2012;69:2429-34. [PMID: 22562580 DOI: 10.1007/s00018-012-1016-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
79 Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V. Adenosine receptors: expression, function and regulation. Int J Mol Sci 2014;15:2024-52. [PMID: 24477263 DOI: 10.3390/ijms15022024] [Cited by in Crossref: 172] [Cited by in F6Publishing: 142] [Article Influence: 24.6] [Reference Citation Analysis]
80 Liu W, Xu L, Wang X, Zhang D, Sun G, Wang M, Wang M, Han Y, Chai R, Wang H. PRDX1 activates autophagy via the PTEN-AKT signaling pathway to protect against cisplatin-induced spiral ganglion neuron damage. Autophagy 2021;:1-23. [PMID: 33749526 DOI: 10.1080/15548627.2021.1905466] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
81 Kempfle JS. Endoscopic-Assisted Drug Delivery for Inner Ear Regeneration. Otolaryngol Clin North Am 2021;54:189-200. [PMID: 33243375 DOI: 10.1016/j.otc.2020.09.022] [Reference Citation Analysis]